약병원성 조류인플루엔자 사독백신개발을 위한 후보주(A0401)의 면역 원성 및 안정성 평가 = Evaluation on Immunogenicity and Safety of Avian Influenza Isolate(ADL0401) as a Candidate for the Killed Vaccine against Low-Pathogenic Avian Influenza

다국어 초록 (Multilingual Abstract)

Avian influenza (AI) virus (AIV) is distributed worldwide and it has been isolated from various species of wild and domestic birds. AI transfers with high speed and shows diverse pathogenicity syndroms. In Korea, several low pathogenic AIV, H9N2, have been isolated from the commercial farms with severe decrease of egg production and mortality resulted in severe economic loss since 1996. Therefore, it has been requested to develop AI vaccines to prevent clinical signs and economic losses from the field infection of AIV. To develop a killed vaccine that efficiently prevents low pathogenic AIV (H9N2), evaluation on the pathogenicity and selection of an inactivator for H9N2 is taking place and is being tested safety and immunogenicity of vaccine produced. Based on the pathogenicity test and viral reisolation test, the ADL0401 isolate is the characteristic low pathogenic AIVs and has fairly similar biologic functions compared with MS96 which is the official low pathogenic AIV (H9N2) and one of the predominant AIV isolated from poultry farms in Korea. In antigenicity tests, the ADL0401 and MS96 virus have no significant antigenic difference. In inactivation tests, the ADL0401 isolates can be easily inactivated with 0.1% Formalin at 37℃ within 1 hour with a little decrease of HA titer. The vaccine developed in the present report has no harmful effect on bird and forms good immune capability. Therefore, the isolates, ADL0401 can be used for a killed vaccine which can reduce the clinical signs and viral shedding in the birds infected with H9N2 low pathogenic AIVs.

국문 초록 (Abstract)

본 연구는 약병원성 조류인플루엔자 사독백신 개발을 위하여 백신 후보주(ADL0401)로서의 생물학적 특성 및 개발 백신에 대한 면역원성 및 안전성 평가를 실시하였다.
백신 후보주인 ADL0401의 병원성을 조사한 결과 폐사는 없었으며, 임상증상 및 바이러스 재분리율 양상이 국내 표준야외주인 MS96과 상당히 유사한 생물학적 특성을 나타내어 약병원성 조류인플루엔자의 특징을 갖고 있음을 알 수 있었다.
표준야외주인 MS96과 백신후보주인 ADL0401간의 이종항원의 중화능 실험을 한 결과 r값 = 0.71로 동종항원(r값 = 1)에 비하여 다소 낮은 중화능을 나타내었지만, 두 바이러스간의 항원성엔 큰 차이가 없음을 알 수 있었다.
불활화 능력실험으로 0.1% Formalin을 37℃ 조건에서 처리하였을 때 가장 효과적인 결과를 가져왔으며, MS96은 2시간, ADL0401은 1시간만에 다소의 역가 저하는 있었으나 빠르게 불활화가 이루어짐을 확인하였다.
개발 백신의 면역원성 및 안전성 실험 결과 ISA 70 adjuvant 백신 접종시 백신 접종 전후로 폐사율 및 임상증상은 관찰되지 않았으며, 높은 수준의 항체 역가를 형성함으로써 가장 면역원성이 우수한 것으로 확인되었다.

참고문헌 (Reference)

1 "공중보건 위생측면에서의 조류 인플루엔자 바이러스 및 최근 국내 유행주의 특성" 5-16, 2003

2 "terization of avian H5N1 influenza viruses from poultry in Hong Kong" 252 : 331-342,

3 "outbreak in Iran" 828-831, asasik2003avianinfluenza

4 "avian influenza and infectious bronchitis" 31 : 154-162,

5 "and C viruses" 215 : 1468-1474,

6 "World Health Organization Report 1973 Influenza neuraminidase and neuraminidase-inhibition test procedures" 48 : 199-203,

7 "Webster RG 2003 The quest of influenza a viruses for new hosts" 849-856, 2003

8 "Webster RG 1999 Molecularcharacterization of H9N2 influenza viruses were they the donors of the genes of H5N1 viruses in Hong Kong" 9363-9367, 1999

9 "Webster RG 1988 Sequence requirement for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells" 85 : 324-328,

10 "Swayne DE Evaluation of a high-pahogenicity H5N1 avian influenza A virus isolated from duck meat" 951-955, 2003

11 "Senne DA Sequence analysis of related low- pathogenic and highly pathogenic H5N2 avian influenza isolates from United States live bird markets and poultry farms from 1983 to 1989" 44 : 356-364, 2000

12 "Senne DA 2000 Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia" 267 : 279-288, 2000

13 "Pearson JE 1995 Presence of avian influenza virus subtypes H5N2 and H7N1 in emus" dromaius (dromaius): 64-67, 1995

14 "Pathological lesions in the lungs of ducks infected with influenza A viruses" 1-5,

15 "Orthomyxoviridae: The viruses and their replication. In: Field virology" Lippincott Williams and Wildins chapter 46 : 1487-1532, 2001

16 "Mason PR 1994 A broad-spectrum avian influenza subtype antigen for indirect enzyme-linked immunosorbent assay for antibodies against poultry pathogens in ostriches" Davelaar F 621-625,

17 "Manwell RJ 1986 Experimental assessment of the pathogenicity of eight influenza A viruses of N5 subtype for chickens" 647-662,

18 "Malik SA 2003 Evaluation of pathogenic potential of avian influenza virus serotype H9N2 in chickens" ba (ba): 817 1-822 3,

19 "M IP of isolate MS96" 44 : 527-535, 2000

20 "Klopp S 1981 Severe egg-production drops in turkey breeders in Southcentral Missouri" 25 : 764-767,

21 "Kawaoka Y 1994 Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses" 6074-6078,

22 "Kawaoka Y 1992 Location and character of the cellular enzyme that cleavage the hemagglutinin of a virulent avian influenza virus" 278-190 287,

23 "Hurst A 1957 Approaches to the chemotherapy of virus diseases" 9 : 273-292,

24 "Horsfall FL 1950 Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum" 92 : 441-462,

25 "Hashemzadeh M 1999 Efficacy of inactivated H9N2 avian influenza vaccine against non-highly pathogenic A/Chicken/Iran/ ZMT-101/98 infection"

26 "Gough RE 1986 Isolations of avian influenza virus from birds in Great Britain" 118 : 537-538,

27 "Garten W 1992 Influenza virus hemagglutinin with multibasic cleavage site is activated by furin" 2407-2414,

28 "Garten W 1992 Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition Motif R-X-K/R-R" 408-188 413,

29 "Fransis T 1936 Jr Proc Soc Exp Biol and Med" 35 : 463-,

30 "Diseases of Poultry" Iowa State University Press Ames IA 583-605,

31 "Chin RP 2001 Enhanced recovery of avian influenza virus isolates by a combination of chicken embryo inoculation methods" 45 : 1030-1035, 2001

32 "Charles WB 2001 Efficasy of vaccine in chickens against highly pathogenic Hong Kong H5N1 avian influenza" 45 : 355-365, 2001